Dr Thomas L Kennedy, MD | |
100 N Academy Ave, Danville, PA 17822-1333 | |
(570) 271-6429 | |
Not Available |
Full Name | Dr Thomas L Kennedy |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 51 Years |
Location | 100 N Academy Ave, Danville, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588623821 | NPI | - | NPPES |
000692220 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD023371E (Pennsylvania) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Geisinger Clinic | 5395657001 | 2866 |
News Archive
Heralded a miracle by many infertile couples, in vitro fertilization (IVF) can pack a painful financial punch for those without insurance coverage for the treatment. This prohibitive cost leads many would-be parents who pursue in vitro fertilization to transfer multiple embryos at once to increase their chances of getting a baby - and reduce the need to pay for subsequent attempts.
Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university's groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company's lead anti-infective and vaccine product candidates.
› Verified 1 days ago
Entity Name | Geisinger Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Heralded a miracle by many infertile couples, in vitro fertilization (IVF) can pack a painful financial punch for those without insurance coverage for the treatment. This prohibitive cost leads many would-be parents who pursue in vitro fertilization to transfer multiple embryos at once to increase their chances of getting a baby - and reduce the need to pay for subsequent attempts.
Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university's groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company's lead anti-infective and vaccine product candidates.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas L Kennedy, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Thomas L Kennedy, MD 100 N Academy Ave, Danville, PA 17822-1333 Ph: (570) 271-6429 |
News Archive
Heralded a miracle by many infertile couples, in vitro fertilization (IVF) can pack a painful financial punch for those without insurance coverage for the treatment. This prohibitive cost leads many would-be parents who pursue in vitro fertilization to transfer multiple embryos at once to increase their chances of getting a baby - and reduce the need to pay for subsequent attempts.
Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university's groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company's lead anti-infective and vaccine product candidates.
› Verified 1 days ago
Dr. Thorsen Wayne Haugen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 | |
Aileen Wertz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 | |
Dr. Jeremy Alexander Mock, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 | |
Linda Gage-white, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 Fax: 570-271-6854 | |
Jeff Wong, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 | |
Dr. Joseph Scott Greene, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6429 | |
James Barrese, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-5681 |